2018 Report of the Treasurer
Jack W. “Jay” Campbell IV, JD, RPh, presented the Report of the Treasurer during the 114th Annual Meeting: “Good afternoon! Thank you for the honor of serving as your treasurer this year, and for the opportunity to speak to you today. I will be presenting a high-level – or, in keeping with this year’s mountain […]
Read More ›2018 President’s Address
Jeanne D. Waggener, RPh, DPh, presented the President’s Address during the 114th Annual Meeting: “Good afternoon. It is hard for me to believe that a year has passed and I am standing before you delivering my last report as President of NABP. Other NABP Presidents warned me that the year would fly by. However, until […]
Read More ›2018 Report of the Executive Committee
Hal Wand, MBA, RPh, presented the Report of the Executive Committee during the 114th Annual Meeting: “Good afternoon. Once again, I stand before you humbled to have served on your Executive Committee, a privilege I have held for the past ten years. In my time serving as an officer on the NABP executive committee, I have also […]
Read More ›NABP 114th Annual Meeting to Convene in the ‘Mile High City’
Business Sessions, CPE Programs, Networking Events, and More Await Attendees For the first time since 1942, the National Association of Boards of Pharmacy® (NABP®) will convene in Denver, CO, to host its Annual Meeting. Themed “To Climb Upward, We Must Think Forward,” the 114th Annual Meeting will provide attendees an opportunity to explore the “Mile […]
Read More ›Recognition Resolution (Resolution 113-7-17)
Resolution No: 113-7-17 Title: Recognition Resolution Action: PASS WHEREAS, the individuals listed here have made significant contributions to NABP, the protection of the public health, and the practice of pharmacy: Allan L. Brinkhaus (LA) Jacqueline M. Carson (VA) Thomas Dickson (MN) John A. Foust (OK) John O. LeTard (LA) Kendall M. Lynch (TN) Pauline Montgomery […]
Read More ›Best Practices for Veterinary Compounding (Resolution 113-1-17)
Resolution No: 113-1-17 Title: Best Practices for Veterinary Compounding Action: PASS WHEREAS, the compounding of medications for human use is regulated by the state boards of pharmacy through statutes, regulations, and applicable standards such as United States Pharmacopeia Chapters and and Food and Drug Administration (FDA), where applicable; and WHEREAS, pharmacists who oversee or are […]
Read More ›Definition of a Patient-Pharmacist Relationship (Resolution 113-2-17)
Resolution No: 113-2-17 Title: Definition of a Patient-Pharmacist Relationship Action: PASS WHEREAS, a patient-physician relationship is generally formed when a physician agrees to assume care for a patient. Once the physician consensually enters into a relationship with a patient in any of these ways, a legal obligation is established in which the physician owes a […]
Read More ›Experiential Learning for Non-US Pharmacists and Students (Resolution 113-3-17)
Resolution No: 113-3-17 Title: Experiential Learning for Non-US Pharmacists and Students Action: PASS WHEREAS, there is an increasing interest in global exchange programs that provide practitioners and pharmacy students opportunities to learn about pharmacy services in the United States and other countries; and WHEREAS, international students coming to US schools and colleges of pharmacy and […]
Read More ›Task Force on Long-Term Care Pharmacy Rules (Resolution 113-4-17)
Resolution No: 113-4-17 Title: Task Force on Long-Term Care Pharmacy Rules Action: PASS WHEREAS, there is an increase in the practice of long-term care pharmacy due to the aging of the United States population; and WHEREAS, some state pharmacy laws and regulations have not evolved with this growing practice, including but not limited to the […]
Read More ›Adjudication of Concurrent Disciplinary Actions (Resolution 113-5-17)
Resolution No: 113-5-17 Title: Adjudication of Concurrent Disciplinary Actions Action: PASS WHEREAS, the authority of state boards of pharmacy to enforce concurrent sister-state disciplinary actions can be an effective mechanism for regulating multi-state practices; and WHEREAS, the potential for concurrent sister-state disciplinary actions may impact the initiating state board of pharmacy to fully adjudicate a […]
Read More ›